Francis Navarro
Overview
Explore the profile of Francis Navarro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
855
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al Taweel B, Cassese G, Khayat S, Chazal M, Navarro F, Guiu B, et al.
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893103
: Liver venous deprivation (LVD) is a recent radiological technique that has shown promising results on Future Remnant Liver (FRL) hypertrophy. The aim of this retrospective study is to compare...
2.
Sommier L, Lim C, Jeune F, Goumard C, Turco C, Salloum C, et al.
HPB (Oxford)
. 2024 May;
26(8):1033-1039.
PMID: 38806366
Background: Appropriate risk stratification for the difficulty of liver transplantation (LT) is essential to guide the selection and acceptance of grafts and avoid morbidity and mortality. Methods: Based on 987...
3.
Laroche S, Lim C, Goumard C, Rayar M, Cherqui D, Chiche L, et al.
HPB (Oxford)
. 2024 Feb;
26(4):586-593.
PMID: 38341287
Background: There are no data to evaluate the difference in populations and impact of centers with liver transplant programs in performing laparoscopic liver resection (LLR). Methods: This was a multicenter...
4.
Ferrari C, Leon P, Falconi M, Boggi U, Piardi T, Sulpice L, et al.
Langenbecks Arch Surg
. 2023 Sep;
408(1):386.
PMID: 37776339
Background: Due to delayed diagnosis and a lower surgical indication rate, left-sided pancreatic ductal adenocarcinoma (PDAC) is often associated with a poor prognosis in comparison to pancreatic head tumors. Multi-visceral...
5.
Daniel J, Dumortier J, Del Bello A, Gamon L, Molinari N, Faure S, et al.
JHEP Rep
. 2023 Sep;
5(10):100832.
PMID: 37681206
Background & Aims: Liver transplantation (LT) is a last resort treatment for patients at high risk of mortality from end-stage liver disease. Over the past years, alcohol-associated liver disease has...
6.
Toubert C, Guiu B, Al Taweel B, Assenat E, Panaro F, Souche F, et al.
Cancers (Basel)
. 2023 Jan;
15(1).
PMID: 36612227
Surgical resection is the optimal treatment for HCC, despite a high risk of recurrence. Few data are available on patient’s survival after resection. This is a retrospective study of tumor...
7.
Seckler F, Turco C, Mohkam K, Addeo P, Robin F, Cauchy F, et al.
Transplantation
. 2022 Dec;
107(3):664-669.
PMID: 36477606
Background: In the current setting of organ shortage, brain-dead liver donors with recent liver trauma (RLT) represent a potential pool of donors. Yet, data on feasibility and safety of liver...
8.
Al Taweel B, Cassese G, Chanques G, Bouyabrine H, Herrero A, Navarro F, et al.
Updates Surg
. 2022 Nov;
75(3):553-561.
PMID: 36376559
Risk factors for gastrointestinal (GI) perforations in adult liver transplantation (LT) recipients have never been deeply investigated, as well as their management. The aim of this study is to report...
9.
Herrero A, Boivineau L, Cassese G, Assenat E, Riviere B, Faure S, et al.
Transpl Int
. 2022 Apr;
35:10412.
PMID: 35401038
Microvascular invasion (MVI) is one of the main prognostic factors of hepatocellular carcinoma (HCC) after liver transplantation (LT), but its occurrence is unpredictable before surgery. The alpha fetoprotein (AFP) model...
10.
Julio C, Benoist S, Allard M, Navarro F, Pessaux P, Sa Cunha A, et al.
J Surg Oncol
. 2022 Apr;
126(2):330-338.
PMID: 35397122
Background: outcome of patients who develop resectable metachronous colorectal liver metastases (CLM) after adjuvant oxaliplatin-based chemotherapy for Stage III colorectal cancer (CRC) is not well defined and the value of...